Literature DB >> 12480958

Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.

Joseph C K Leung1, Sydney C W Tang, Loretta Y Y Chan, Anita W L Tsang, Hui Yao Lan, Kar Neng Lai.   

Abstract

BACKGROUND: It has been suggested that polymeric IgA (pIgA) or IgA immune complexes play a significant pathogenic role in IgA nephropathy (IgAN). Macrophage migration inhibitory factor (MIF) shares many activities with other pro-inflammatory cytokines. In human glomerulonephritis, including IgAN, glomerular expression of MIF is found to correlate with progressive renal injury. We hypothesized that deposition of pIgA within the kidney may lead to enhanced synthesis of MIF by mesangial cells.
METHODS: In this study we examined the effect of pIgA and monomeric IgA (mIgA) from randomly selected patients with IgAN in clinical quiescence on the gene expression and protein synthesis of MIF in cultured human mesangial cells (HMC).
RESULTS: Both pIgA and mIgA from IgAN patients or matched healthy controls increased MIF gene expression and protein synthesis in a dose-dependent fashion. The magnitude of MIF protein induction by pIgA (100 microg/ml) was similar to that of tumour necrosis factor-alpha (TNF-alpha) at 10 pg/ml. In all subjects, the induction of MIF was higher for pIgA when compared with mIgA (P < 0.01). Furthermore, the up-regulation of MIF synthesis by either pIgA or mIgA was significantly higher in IgAN patients than in healthy controls (P < 0.05). Similarly, pIgA and mIgA were able to induce TNF-alpha gene expression and protein synthesis in mesangial cells. Incubation of mesangial cells with neutralizing antibody to TNF-alpha reduced the MIF synthesis induced by pIgA.
CONCLUSION: We demonstrate that pIgA is capable of inducing MIF and TNF-alpha production in HMC, which may play a major pathogenic role in IgAN. Induction of MIF can be partially blocked by neutralizing antibody to TNF-alpha, suggesting the possibility that up-regulation of MIF synthesis in HMC is mediated via an amplifying proinflammatory loop involving TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480958     DOI: 10.1093/ndt/18.1.36

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  20 in total

1.  Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.

Authors:  Grigorios T Sakellariou; Periklis Vounotrypidis; Charalampos Berberidis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 2.980

Review 2.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

3.  MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.

Authors:  Akinobu Ochi; Dong Chen; Wibke Schulte; Lin Leng; Nickolas Moeckel; Marta Piecychna; Luisa Averdunk; Christian Stoppe; Richard Bucala; Gilbert Moeckel
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-24

4.  Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules.

Authors:  Y-H Gao; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2007-03-26       Impact factor: 4.330

Review 5.  Macrophage Migration Inhibitory Factor (MIF) as a Stress Molecule in Renal Inflammation.

Authors:  Yao-Zhong Kong; Qiyan Chen; Hui-Yao Lan
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

6.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

7.  Clinical, Laboratory, and Radiologic Manifestation of SARS.

Authors:  Kar Neng Lai; Kenneth W. Tsang; Wing Hong Seto; Clara G. C. Ooi
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

8.  Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74.

Authors:  Sonja Djudjaj; Hongqi Lue; Song Rong; Marios Papasotiriou; Barbara M Klinkhammer; Stephanie Zok; Ole Klaener; Gerald S Braun; Maja T Lindenmeyer; Clemens D Cohen; Richard Bucala; Andre P Tittel; Christian Kurts; Marcus J Moeller; Juergen Floege; Tammo Ostendorf; Jürgen Bernhagen; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

9.  Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.

Authors:  Zina Moldoveanu; Hitoshi Suzuki; Colin Reily; Kenji Satake; Lea Novak; Nuo Xu; Zhi-Qiang Huang; Barbora Knoppova; Atlas Khan; Stacy Hall; Hiroyuki Yanagawa; Rhubell Brown; Colleen J Winstead; Darrell B O'Quinn; Amy Weinmann; Ali G Gharavi; Krzysztof Kiryluk; Bruce A Julian; Casey T Weaver; Yusuke Suzuki; Jan Novak
Journal:  J Autoimmun       Date:  2021-01-25       Impact factor: 7.094

10.  Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.

Authors:  Rafał Zwiech
Journal:  BMC Immunol       Date:  2015-08-14       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.